GSA Capital Partners’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$926K Sell
9,639
-7,728
-44% -$706K 0.06% 559
2026
Q1
$644K Buy
+17,367
New +$556K 0.04% 759
2025
Q3
Sell
-118,700
Closed -$1.53M 1609
2025
Q2
$1.53M Buy
+118,700
New +$1.13M 0.11% 226
2024
Q4
Sell
-137,861
Closed -$1.77M 1567
2024
Q3
$1.77M Sell
137,861
-94,823
-41% -$1.37M 0.13% 164
2024
Q2
$2.6M Buy
232,684
+63,548
+38% +$740K 0.18% 73
2024
Q1
$2.1M Buy
169,136
+131,384
+348% +$2.19M 0.17% 86
2023
Q4
$1M Buy
+37,752
New +$1.1M 0.08% 392
2022
Q3
Sell
-19,951
Closed -$150K 1469
2022
Q2
$150K Sell
19,951
-15,315
-43% -$127K 0.02% 1144
2022
Q1
$358K Sell
35,266
-3,330
-9% -$42.6K 0.05% 765
2021
Q4
$933K Buy
+38,596
New +$754K 0.12% 233

Other funds holding AEHR

GSA Capital Partners's AEHR Position: Q2 2026 in Review

GSA Capital Partners reduced its Aehr Test Systems (AEHR) stake by 44% in Q2 2026, selling an estimated $706K and leaving 9,639 shares worth $926K. The position accounts for 0.06% of the portfolio, ranked #559.

GSA Capital Partners first reported a position in AEHR in Q4 2021 and has held it in 10 quarters since. The position peaked at $2.6M in Q2 2024. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • GSA Capital Partners held 9,639 shares of Aehr Test Systems worth $926K as of Q2 2026.
  • GSA Capital Partners sold 7,728 Aehr Test Systems shares in Q2 2026, an estimated $706K.
  • Aehr Test Systems made up 0.06% of GSA Capital Partners's portfolio in Q2 2026, its #559 holding.
  • GSA Capital Partners first reported a position in Aehr Test Systems in Q4 2021 and has held it in 10 quarters since.
  • GSA Capital Partners's Aehr Test Systems position peaked at $2.6M in Q2 2024.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.